Neurocarrus Inc

Neurocarrus Inc is a biotech company in Monterey, United States, founded in 2017. It has raised $354K across 3 rounds, most recently a $344K SAFE in April 2019.

Targeted pain relief without addiction.

Employees
1–10
Founded
2017
Business Model
B2B
Total Funding
$354K
Last Round
$344K SAFEApr 2019
Rounds
3

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 3 funding rounds and 2 investors for this company. The full record is or through the API.

About

Neurocarrus is a pre-clinical biotechnology company developing targeted protein therapeutics for pain management and neurological disorders without addiction risk. Its Apollo drug delivery platform engineers proteins to target and deliver therapeutics directly to selected tissues and cells. Lead assets include N-001 for acute surgical pain, NL-17 for migraine prevention, and N-19a for chronic pain — all designed to provide lasting relief without opioid-associated side effects. The company is backed by NIH SBIR grants and has partnered with Stanford University and the VA Palo Alto Medical Center.

Summary

It lists 1–10 employees. It has raised $354K in total across 3 rounds, most recently a $344K SAFE round in Apr 2019. Investors include SOSV and National Institute on Drug Abuse.

Tech & App Stack

6 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Data from Indexed.vcUpdated
SAFEApr 2019
$344K

Sign up to see all 3 events

Funding: Seed through SAFE. Amounts, valuations, and investors where available.

Investors

Similar Companies

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017
BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech, Oncology
Corporate RoundTotal funding$2.8BJan 2020

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Neurocarrus Inc on Indexed.vc
<a href="https://indexed.vc/companies/neurocarrus-inc"><img src="https://indexed.vc/api/badge/company/neurocarrus-inc" alt="Neurocarrus Inc on Indexed.vc" width="260" height="76" /></a>